Alignment Healthcare, Inc.

NasdaqGS:ALHC Rapporto sulle azioni

Cap. di mercato: US$2.3b

Alignment Healthcare Gestione

Gestione criteri di controllo 3/4

Alignment Healthcare Il CEO è John Kao, nominato in Jan2014, e ha un mandato di 10.83 anni. la retribuzione annua totale è $ 14.30M, composta da 5.5% di stipendio e 94.5% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 1.51% delle azioni della società, per un valore di $ 35.13M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 5.6 anni e 9.5 anni.

Informazioni chiave

John Kao

Amministratore delegato

US$14.3m

Compenso totale

Percentuale dello stipendio del CEO5.5%
Mandato del CEO10.8yrs
Proprietà del CEO1.5%
Durata media del management5.6yrs
Durata media del Consiglio di amministrazione9.5yrs

Aggiornamenti recenti sulla gestione

Recent updates

A Piece Of The Puzzle Missing From Alignment Healthcare, Inc.'s (NASDAQ:ALHC) 30% Share Price Climb

Nov 07
A Piece Of The Puzzle Missing From Alignment Healthcare, Inc.'s (NASDAQ:ALHC) 30% Share Price Climb

Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Intrinsic Value Is Potentially 73% Above Its Share Price

Oct 14
Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Intrinsic Value Is Potentially 73% Above Its Share Price

Even With A 30% Surge, Cautious Investors Are Not Rewarding Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Performance Completely

Sep 12
Even With A 30% Surge, Cautious Investors Are Not Rewarding Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Performance Completely

Alignment Healthcare (NASDAQ:ALHC) Has Debt But No Earnings; Should You Worry?

Sep 10
Alignment Healthcare (NASDAQ:ALHC) Has Debt But No Earnings; Should You Worry?

Earnings Update: Here's Why Analysts Just Lifted Their Alignment Healthcare, Inc. (NASDAQ:ALHC) Price Target To US$9.55

Aug 04
Earnings Update: Here's Why Analysts Just Lifted Their Alignment Healthcare, Inc. (NASDAQ:ALHC) Price Target To US$9.55

Market Might Still Lack Some Conviction On Alignment Healthcare, Inc. (NASDAQ:ALHC) Even After 27% Share Price Boost

Jul 18
Market Might Still Lack Some Conviction On Alignment Healthcare, Inc. (NASDAQ:ALHC) Even After 27% Share Price Boost

Is Now An Opportune Moment To Examine Alignment Healthcare, Inc. (NASDAQ:ALHC)?

Jul 12
Is Now An Opportune Moment To Examine Alignment Healthcare, Inc. (NASDAQ:ALHC)?

An Intrinsic Calculation For Alignment Healthcare, Inc. (NASDAQ:ALHC) Suggests It's 26% Undervalued

Jun 20
An Intrinsic Calculation For Alignment Healthcare, Inc. (NASDAQ:ALHC) Suggests It's 26% Undervalued

The Market Lifts Alignment Healthcare, Inc. (NASDAQ:ALHC) Shares 37% But It Can Do More

May 30
The Market Lifts Alignment Healthcare, Inc. (NASDAQ:ALHC) Shares 37% But It Can Do More

Is Alignment Healthcare (NASDAQ:ALHC) Weighed On By Its Debt Load?

Apr 19
Is Alignment Healthcare (NASDAQ:ALHC) Weighed On By Its Debt Load?

It's A Story Of Risk Vs Reward With Alignment Healthcare, Inc. (NASDAQ:ALHC)

Feb 24
It's A Story Of Risk Vs Reward With Alignment Healthcare, Inc. (NASDAQ:ALHC)

Does Alignment Healthcare (NASDAQ:ALHC) Have A Healthy Balance Sheet?

Jan 18
Does Alignment Healthcare (NASDAQ:ALHC) Have A Healthy Balance Sheet?

Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Subdued P/S Might Signal An Opportunity

Nov 08
Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Subdued P/S Might Signal An Opportunity

Alignment Healthcare: Investors Should Align Themselves With Insiders

Oct 05

Alignment Healthcare announces 9M shares secondary offering

Sep 15

Alignment Healthcare completes debt refinancing

Sep 06

Alignment Healthcare: This Next-Generation Medicare Startup Is Fully Valued

Aug 22

Alignment Health Plan plans to expand into three Nevada counties

Jul 20

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di John Kao rispetto agli utili di Alignment Healthcare?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2024n/an/a

-US$144m

Jun 30 2024n/an/a

-US$153m

Mar 31 2024n/an/a

-US$157m

Dec 31 2023US$14mUS$787k

-US$148m

Sep 30 2023n/an/a

-US$158m

Jun 30 2023n/an/a

-US$163m

Mar 31 2023n/an/a

-US$146m

Dec 31 2022US$34mUS$730k

-US$150m

Sep 30 2022n/an/a

-US$140m

Jun 30 2022n/an/a

-US$146m

Mar 31 2022n/an/a

-US$179m

Dec 31 2021US$46mUS$675k

-US$195m

Sep 30 2021n/an/a

-US$180m

Jun 30 2021n/an/a

-US$123m

Mar 31 2021n/an/a

-US$70m

Dec 31 2020US$4mUS$657k

-US$23m

Compensazione vs Mercato: La retribuzione totale di John ($USD 14.30M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 5.43M ).

Compensazione vs guadagni: La retribuzione di John è stata coerente con le performance aziendali dell'ultimo anno.


AMMINISTRATORE DELEGATO

John Kao (62 yo)

10.8yrs

Mandato

US$14,296,476

Compensazione

Mr. John E. Kao is Chairman & CEO of Alignment Health Plan of Illinois, Inc. from 2022. Mr. Kao has been Director of Alignment Health Plan of Illinois, Inc. He is the Founder of Alignment Healthcare, Inc....


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
John Kao
Founder10.8yrsUS$14.30m1.51%
$ 35.1m
Robert Freeman
Chief Financial Officer7.8yrsUS$6.30m0.23%
$ 5.4m
Hyong Kim
Chief Medical Officer1.2yrsUS$3.06m0.072%
$ 1.7m
Dawn Maroney
President of Health Markets & CEO of Health Plan10.8yrsUS$6.46m0.53%
$ 12.2m
Hakan Kardes
Chief Experience Officerless than a yearUS$3.22m0.19%
$ 4.3m
Donald Furman
Co-Founder & Chief Clinical Officerno dataNessun dato0.80%
$ 18.6m
Charlotte LeBlanc
Chief Accounting Officer and Senior Vice Presidentno dataNessun datoNessun dato
Robert Scavo
Chief Information Officer4.2yrsNessun dato0.10%
$ 2.3m
Christopher Joyce
Chief Legal & Administrative Officer1.3yrsNessun dato0.026%
$ 613.3k
Andreas Wagner
Chief Human Resources Officerless than a yearNessun datoNessun dato
Sergio Zaldivar
Senior Vice President of Business Operations7.9yrsNessun datoNessun dato
Kerry Matsumoto
Senior Vice President of Clinical Product7.1yrsNessun datoNessun dato

5.6yrs

Durata media

56yo

Età media

Gestione esperta: Il team dirigenziale di ALHC è esperto e expertise (durata media dell'incarico 5.6 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
John Kao
Founder10.8yrsUS$14.30m1.51%
$ 35.1m
David Hodgson
Independent Director10.8yrsUS$270.00k0.045%
$ 1.0m
Joseph Konowiecki
Independent Chairman of the Board10.8yrsUS$2.25m0.47%
$ 10.8m
N. Vorhoff
Independent Director10.8yrsUS$270.00k0.045%
$ 1.0m
Jacqueline Kosecoff
Independent Director7.8yrsUS$265.63k0.12%
$ 2.9m
Yon Jorden
Independent Director2.8yrsUS$260.00k0.021%
$ 496.4k
Jody Bilney
Independent Director2.8yrsUS$257.50k0.025%
$ 584.3k
Margaret McCarthy
Lead Independent Director3.9yrsUS$280.42k0.043%
$ 1.0m
Mark McClellan
Independent Director10.8yrsUS$250.00k0.16%
$ 3.8m
Melanie Bella
Member of Advisory Board8.1yrsNessun datoNessun dato

9.5yrs

Durata media

68.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di ALHC sono considerati esperti (durata media dell'incarico 9.5 anni).